Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review examines alopecia as a side effect of psychotropic medications, noting that it is typically reversible after stopping the drug, but it reports no new results.

In this case study, researchers reported a 37-year-old woman with androgenetic alopecia and chronic telogen effluvium experienced significant hair growth improvement after personalized integrative treatment, including caffeine application, following a four-month protocol incorporating various therapies.

This study found a significant association between lower serum ferritin levels and chronic diffuse hair loss in women of reproductive age, particularly in cases of alopecia areata and androgenetic alopecia.

This case report describes a young woman with hypopituitarism who experienced hair loss typical of female androgenetic alopecia without detectable androgens, suggesting this hair loss pattern may not always be androgen dependent.

This report from the National Registry of Drug-Induced Ocular Side Effects identifies 56 cases of alopecia associated with the use of topical ophthalmic β-blockers.

This case report highlights the importance of suspecting underlying malignancy, such as Hodgkin's lymphoma, in patients with diffuse hair loss and other cutaneous symptoms.

This case report describes a middle-aged man with alopecia universalis and ulcerative colitis, where hair regrowth occurred following treatment with azathioprine and mesalamine.

This case report describes a 21-year-old male who experienced sertraline-induced diffuse hair loss that improved after discontinuing the medication.

This letter to the editor discusses a previous clinical and histopathological analysis of four cases of severe diffuse non-scarring hair loss in systemic lupus erythematosus, reporting no new study results.

This review discusses the onset and characteristics of telogen effluvium following SARS-CoV-2 infection, implicating stress, cytokine release, or viral damage, and reports no new clinical results.

This study found that treatment modalities and patch size influence hair regrowth patterns in alopecia areata patches.

This study reported that androgenetic alopecia in women becomes more prevalent with age, with risk factors including heredity and endocrine disorders, and differs clinically from male-pattern hair loss by causing diffuse hair thinning rather than loss at the temples or crown.

This study provides an updated overview of non-scarring alopecia in lupus erythematosus patients, revealing that diffuse/patchy NSA and lupus hair are strongly associated with systemic activity and respond well to SLE therapy, while progression to scarring alopecia was rare.

This report describes a case of Cronkhite-Canada syndrome diagnosed in a 54-year-old man with symptoms including gastrointestinal polyps, alopecia, skin hyperpigmentation, and severe diarrhea, who experienced significant symptom improvement with azathioprine.

This letter discusses the potential role of zinc deficiency in hypothyroid infants with alopecia due to levothyroxine overdose and reports no new results.

This case study identified the condition as Monilethrix in a 17-year-old female, characterized by a beaded hair appearance and linked to a genetic cause.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

This report suggests that fluvoxamine use may be associated with hair loss, as observed in a 28-year-old male whose condition improved after stopping the drug.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

This case report describes two brothers with an unusual, possibly treatment-resistant inflammatory variant of androgenic alopecia, featuring follicular isthmic lymphocytic inflammation and diffuse central scalp hair loss.

This review discusses the classification of lichen planopilaris and its subtypes under the proposed term "lichenoid alopecias," suggesting they exist along a clinical and histological spectrum.

This study reported that atypical variants of alopecia areata made up less than 25% of all cases in their specialized trichology unit, suggesting a potential selection bias.

This study found no significant association between low serum ferritin (iron deficiency) and chronic diffuse hair loss in women of reproductive age.

This study suggests that male androgenetic alopecia and female pattern hair loss follow distinct progression pathways, characterized by different trichoscopic patterns related to hair diameter and follicular unit changes.

This research reports that herb lotions for alopecia areata, particularly those containing salvia miltiorrhiza radix, were effective in promoting hair regrowth in 64.8% of severe cases, akin to DNCB and SADBE.

This study observed that non-scarring diffuse hair loss was common in systemic lupus erythematosus patients, but did not find a significant relationship with the SLE Disease Activity Index.

This case report describes a rare occurrence of primary cutaneous diffuse large B-cell lymphoma, not otherwise specified (PCDLBCL-NOS) on the scalp of a 45-year-old female, highlighting its unusual presentation and the initial treatment response but also noting severe subsequent complications.

This article reviews treatments for androgenetic alopecia and reports no new clinical findings; it highlights interest in therapies like platelet-rich plasma and laser therapy, indicating potential for further research.

In this study, oral iron replacement therapy showed improvement in hair loss severity for some women with low serum ferritin levels, but not all responded.

This report describes a case where a 44-year-old male treated with vorasidenib for diffuse low-grade gliomas developed unexpected hair growth, including in areas of severe hair loss, after one month, highlighting a previously undocumented side effect.